Axios hosts a conversation on the future of health care affordability with a new Biden administration, featuring former CMS administrator Mark McClellan and former Rep. Greg Walden (R-Ore.).
Lawmakers in Springfield are seeking to put together a board to lookout for price gouging.
When it comes to drug pricing, there is no incentive for any one part of the U.S. health care system to change. So it will take a dramatic shift for patients to see lower drug prices any time soon.
Behind the collapse of public trust in America.
The drug pricing issue that could erupt this year.